[1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association;Severe Liver Diseases and Artificialliver Group, Chinese Society of Hepatology, Chinese Medical Association.Diagnostic and treatment guidelines for liver failure (2012 version) [J].Chin J Hepatol, 2013, 21 (3) :177-183. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华肝脏病杂志, 2013, 21 (3) :177-183.
|
[2]Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B (2010 version) [J].J Clin Hepatol, 2011, 27 (1) :Ⅰ-ⅩⅥ. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2010版) [J].临床肝胆病杂志, 2011, 27 (1) :Ⅰ-ⅩⅥ.
|
[3]WISSKIRCHEN K, METZGER K, SCHREIBER S, et al.Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use[J].PLo S One, 2017, 12 (8) :e0182936.
|
[4]LIU M, ZHANG XQ, MAO Q.Features of acute-on-chronic pre-liver failure and establishment of a predictive model for risk of acute-on-chronic liver failure[J].J Clin Hepatol, 2012, 28 (10) :732-734. (in Chinese) 刘明, 张绪清, 毛青.慢加急性肝衰竭前期的概念及预警模型[J].临床肝胆病杂志, 2012, 28 (10) :732-734.
|
[5]SARIN SK, KUMAR A, ALMEIDA JA, et al.Acute-on-chronic liver failure:Consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) [J].Hepatol Int, 2009, 3 (1) :269-282.
|
[6]CHEN J, ZHANG J, HE QS.Role of Toll-like receptors in development and progression of nonalcoholic fatty liver disease[J].J Clin Hepatol, 2015, 31 (7) :1153-1155. (in Chinese) 陈杰, 张晶, 何秋水.Toll样受体在非酒精性脂肪性肝病发生发展中的作用[J].临床肝胆病杂志, 2015, 31 (7) :1153-1155.
|
[7]HSU HY, CHANG MH, NI YH, et al.Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant[J].J Infect Dis, 2013, 207 (7) :1047-1057.
|
[8]KOBAYASHI Y, SUZUKI Y.Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin[J].J Virol, 2012, 86 (7) :3446-3451.
|
[9]CRISPIN M, BOWDEN TA.Antibodies expose multiple weaknesses in the glycan shield of HIV[J].Nat Struct Mol Biol, 2013, 20 (7) :771-772.
|
[10]APPELMAN MD, CHAKRABORTY A, PROTZER U, et al.NGlycosylation of the Na+-taurocholate cotransporting polypeptide (NTCP) determines its trafficking and stability and is required for hepatitis B virus infection[J].PLo S One, 2017, 12 (1) :e0170419.
|
[11]PRANGE R, WERR M, BIRKNER M, et al.Properties of modified hepatitis B virus surface antigen particles carrying pre S epitopes[J].J Gen Virol, 1995, 76 (Pt 9) :2131-2140.
|
[12]YU DM, LI XH, MOM V, et al.N-glycosylation mutations within hepatitis B virus surface major hydrophilic region contributemostly to immune escape[J].J Hepatol, 2014, 60 (3) :515-522.
|
[13]YAO MQ, CHEN J, ZHANG J.Association between hepatitis B virus pre-S/S gene variants and HBV-related liver diseases[J].J Clin Hepatol, 2016, 32 (7) :1406-1408. (in Chinese) 姚明琦, 陈杰, 张晶.HBV前S/S区变异与HBV相关肝病的关系[J].临床肝胆病杂志, 2016, 32 (7) :1406-1408.
|
[14]HAN Z, LV M, SHI Y, et al.Mutation of glycosylation sites in BST-2 leads to its accumulation at intracellular CD63-positive vesicles without affecting its antiviral activity against multivesicular body-targeted HIV-1 and hepatitis B Virus[J].Viruses, 2016, 8 (3) :62.
|
[15]CHEN YL, MO YQ, ZHENG DH, et al.Patients with coexistence of circulating hepatitis B surface antigen and its antibody may have a strong predisposition to virus reactivation during immunosuppressive therapy:A hypothesis[J].Med Sci Monit, 2017, 23:5980-5985.
|
[16]QIAO Y, LU S, XU Z, et al.Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBs Ag/anti-HBs[J].Oncotarget, 2017, 8 (37) :61719-61730.
|